L-Thyroxin (Levothyroxin) ist das am häufigsten verordnete Medikament bei Schilddrüsenunterfunktion (Hypothyreose) in Deutschland. Mehr als fünf Millionen Menschen nehmen es täglich ein. Da es sich um ein Hormon mit einer engen therapeutischen Breite handelt, entscheiden kleinste Details bei der Einnahme über Erfolg oder Misserfolg der Therapie.
.gif)
This article is for informational purposes and does not replace medical advice. For heart palpitations, severe inner restlessness, or sudden chest pain: call 999 or go to A&E immediately.
Levothyroxine is one of the most widely prescribed medications in the UK — and one of the few where the intake routine is just as important as the dose. An incorrect timing or too little gap before coffee or supplements can reduce efficacy by up to 40% — with the result that patients remain chronically underdosed despite taking it daily.
| Property | Details |
|---|---|
| Active substance | Levothyroxine sodium |
| ATC code | H03AA01 (thyroid hormones) |
| Available forms | Tablets (25–200 µg) |
| Half-life | approx. 7 days |
| Therapeutic window | Narrow — even small dose changes affect TSH |
| Prescription only | Yes |
| Common diagnoses | Hypothyroidism, Hashimoto's thyroiditis, after thyroid surgery |
Levothyroxine is synthetically produced — chemically identical to the body's own thyroid hormone T4 (thyroxine). It is the hormone that a healthy thyroid produces and releases into the blood every day. In hypothyroidism, the thyroid produces too little of it — levothyroxine replaces this deficit.
The T4 that is swallowed is initially barely biologically active. It serves as a so-called prohormone: the body converts it on demand into the biologically active form T3 (triiodothyronine). This conversion process takes place mainly in the liver, kidneys, and brain. How much T3 is produced from T4 depends on many factors — including selenium status, kidney health, and stress levels. In some patients who continue to have symptoms despite a normal TSH, impaired T4→T3 conversion may be the reason.
T3 influences virtually every cell in the body: it regulates basal metabolic rate and energy expenditure, heart rate, body temperature, brain function, concentration and mood, as well as fat and glucose metabolism. A well-adjusted levothyroxine therapy therefore does not merely improve individual symptoms, but overall wellbeing as a whole.
This is due to the unusually long half-life of approximately 7 days. After a dose change, it takes 4–6 weeks for the new hormone level to stabilise in the blood. This is why TSH is checked no sooner than 6–8 weeks after an adjustment — earlier measurements do not yet reliably reflect the new equilibrium. The upside of the long half-life: a single missed tablet does not cause an abrupt drop in hormone levels. Record all dose changes in your digital medication plan.
Levothyroxine dosing is highly individual. There is no standard dose that suits everyone. The correct dose depends on body weight, age, the underlying condition, and any residual thyroid function — and it can change over the course of life, for example during pregnancy, after the menopause, or with changes in weight.
| Situation | Typical starting dose | Target dose |
|---|---|---|
| Adults (hypothyroidism) | 25–50 µg/day | 75–150 µg/day |
| Older patients / cardiac disease | 12.5–25 µg/day | Slow increase every 4–6 weeks |
| After total thyroidectomy | 1.6 µg/kg body weight/day | Individually based on TSH |
| Pregnancy (hypothyroidism) | Increase by 25–50% | TSH check every 4 weeks |
An important note for older patients or those with cardiac disease: dose increases here are always made slowly — in steps of 12.5–25 µg every 4–6 weeks. Too rapid an increase can trigger cardiac arrhythmias. Finding the right dose is a process that can take several months — patience and regular TSH checks are the decisive factor.
No medication in general practice has more intake errors than levothyroxine. Bioavailability on an empty stomach is 70–80% — but drops to below 40% with food. This means: anyone who takes levothyroxine with breakfast or with coffee absorbs only half as much as intended. TSH then remains persistently elevated — despite daily intake.
Anyone who cannot manage the correct morning schedule can take levothyroxine in the evening instead — at least 2–3 hours after the last meal. Studies show that evening intake produces comparable and in some cases even slightly better bioavailability. This is because the stomach is usually empty at night and no interfering substances are present. Anyone switching to evening intake should have TSH checked after 6–8 weeks and discuss the change with their doctor.
Levothyroxine is particularly sensitive to other substances in the gastrointestinal tract. The mechanism in most cases is the formation of insoluble complexes: certain minerals and medications chemically bind levothyroxine in the stomach or intestine so that it cannot be absorbed into the blood and is excreted unused. This is not a quality problem with the tablet — it is chemistry.
The most important everyday interaction: iron supplements. Anyone taking levothyroxine and iron at the same time absorbs neither properly. The recommendation: levothyroxine in the morning on an empty stomach, iron at least 2 hours later or in the evening. More on this in the iron article, which explains the golden morning schedule in detail.
| Substance / medication | Effect on levothyroxine | Recommended gap |
|---|---|---|
| Calcium (supplements, milk) | Binds levothyroxine in the stomach → reduced absorption | At least 2–4 hours |
| Iron (supplements) | Chelation → up to 50% less absorption! | At least 2–4 hours |
| Coffee (caffeine) | Accelerates gastric emptying; reduces absorption by up to 36% | At least 30–60 minutes |
| Soy products | Inhibits absorption in the intestine | At least 4 hours |
| Pantoprazole / PPIs | Raised pH reduces tablet dissolution | Consult doctor; dose adjustment may be needed |
| Antacids (aluminium, magnesium) | Bind levothyroxine in the stomach | At least 2–4 hours |
| Cholestyramine / colestipol | Bind levothyroxine strongly in the intestine | At least 4–5 hours |
| Warfarin / anticoagulants | Levothyroxine enhances anticoagulant effect | INR check with every dose adjustment |
Another frequently overlooked problem: pantoprazole and other PPIs raise gastric pH, which can impair dissolution of the levothyroxine tablet. Anyone on long-term PPI therapy who cannot achieve a stable TSH on levothyroxine should discuss this connection with their doctor — sometimes a dose increase or switch to a liquid formulation is sufficient. Check all combinations with the interaction check.
Levothyroxine itself has virtually no side effects when correctly dosed, as it is chemically identical to the body's own hormone. Most reported complaints are not a medication problem — they are signs that the dose is not optimally adjusted. The symptom picture is clear: overdosage and underdosage are almost mirror opposites of each other.
Overdosage feels like hyperthyroidism: the body runs at full speed. Heart palpitations (tachycardia) and irregular heartbeat are the most common complaints, followed by inner restlessness, nervousness, and hand tremor. Sleep disturbances, unintentional weight loss, excessive sweating, and diarrhoea can also occur. Long-term overdosage increases the risk of atrial fibrillation and accelerates bone loss (osteoporosis).
For sudden palpitations exceeding 100 beats per minute at rest, chest pain, or severe breathlessness: seek medical help immediately or call 999.
Underdosage feels like persistent hypothyroidism: the body runs at low power. Persistent fatigue and low motivation despite adequate sleep, sensitivity to cold, weight gain without dietary changes, dry skin, brittle hair, and constipation are typical signs. Low mood and difficulty concentrating are also part of the picture — and are frequently not connected to the thyroid.
Levothyroxine is one of the few medications that is not only safe in pregnancy but, when hypothyroidism is present, absolutely necessary. Untreated hypothyroidism during pregnancy can impair the child's brain development and increase the risk of miscarriage and premature birth. Pregnancy does however change requirements: the dose needs to increase by 25–50%, because the thyroid cannot meet the increased demands of mother and baby on its own.
Many endocrinologists therefore recommend: as soon as a positive pregnancy test is obtained, increase the levothyroxine dose by approximately 25% and then monitor closely. TSH should be below 2.5 mU/L in the first trimester — TSH checks every four weeks are standard during pregnancy. During breastfeeding, only very small amounts of levothyroxine pass into breast milk and it is considered safe.
TSH is the most important monitoring parameter of levothyroxine therapy — and at the same time one of the most frequently misunderstood laboratory values. TSH (thyroid-stimulating hormone) is produced by the pituitary gland. It is essentially the brain's signal to the thyroid: "Produce more hormone!" The higher the TSH value, the stronger this signal — and the greater the deficiency of thyroid hormones in the body. The lower the TSH, the more thyroid hormone is present.
A TSH within the normal range (0.4–4.0 mU/L depending on the laboratory) does not automatically mean the adjustment is optimal. For most patients on levothyroxine therapy, a TSH of 0.4–2.5 mU/L is the target range. Anyone who still has symptoms despite a normal TSH should have fT3 and fT4 additionally measured — and if necessary have T4→T3 conversion investigated.
| Patient group | TSH target range |
|---|---|
| Adults (general) | 0.4–2.5 mU/L (individually up to 4.0 mU/L) |
| Pregnancy (1st trimester) | < 2.5 mU/L |
| Older patients (> 70 years) | Slightly higher values often acceptable (up to 6–8 mU/L) |
| After thyroid cancer | Often suppressed (< 0.1 mU/L) |
Not without medical monitoring afterwards. Levothyroxine has a narrow therapeutic window. Different brands (e.g. Eltroxin, Levothyroxine Wockhardt, various generics) can have minimal differences in bioavailability — and with levothyroxine, small differences are enough to destabilise TSH. Anyone switching between brands should have TSH checked after 6–8 weeks. The MHRA has issued guidance recommending that patients remain on the same brand where possible.
Whether levothyroxine can be stopped depends entirely on the reason it was started. There is no blanket answer — and stopping on one's own initiative is always wrong, as severe hypothyroidism may result.
In Hashimoto's thyroiditis, the autoimmune condition permanently damages the thyroid — in most cases, lifelong treatment is necessary. After total thyroidectomy, treatment is mandatory and permanent, as no endogenous production is possible. In transient hypothyroidism (e.g. after subacute thyroiditis), function can recover — a medically supervised trial of stopping is possible after stabilisation. In subclinical hypothyroidism (borderline elevated TSH without symptoms), a trial of stopping under medical supervision may also be appropriate.
Levothyroxine is one of the most frequently recorded long-term medications in the brite app. The dominant theme: the intake routine and its impact on TSH.
| Observation | Frequency | Typical comment |
|---|---|---|
| Coffee gap not maintained | Very common | "Since I've been keeping the coffee gap consistently, my TSH values are finally stable." |
| Iron/calcium taken at the same time | Common | "I was taking both together — the app flagged the gap requirement." |
| Brand switch without TSH check | Common | "After the pharmacy switched to a generic, my values suddenly didn't add up." |
| Palpitations from too rapid a dose increase | Common | "My doctor increased the dose too quickly — I had palpitations for days." |
| Hair loss as alarm signal | Occasional | "I thought it was the medication — but it was just the adjustment phase." |
Particularly relevant: brand switching by the pharmacy. Pharmacies can dispense generic equivalents when the prescribed brand is not in stock. For most medications this is unproblematic. For levothyroxine, it can destabilise TSH. Patients should actively ask their prescriber to specify a particular brand — or have TSH checked after every pharmacy switch, 6–8 weeks later. MHRA guidance supports brand consistency for levothyroxine.
Levothyroxine and coffee — how much gap is really needed? At least 30 minutes, ideally 60. The study by Benvenga et al. showed a reduction in levothyroxine absorption of up to 36% due to coffee. That sounds substantial — and it is. Anyone who has been drinking coffee immediately after levothyroxine for years has systematically high TSH levels and wonders why the dose always needs increasing. The simplest test: keep a 60-minute gap consistently and have TSH checked after 8 weeks. In many patients, it falls significantly.
Missed levothyroxine — what to do? Because of the 7-day half-life, missing a single dose is clinically almost irrelevant. Hormone levels do not drop immediately. The missed tablet can be taken later the same day — but never double up the next day. If several doses have been missed in a week, inform the doctor. brite's dose reminder prevents these situations.
TSH too high — what to do? A persistently raised TSH means underdosage or poor absorption. Before increasing the dose, always review the intake routine: coffee gap, concurrent iron or calcium intake, brand switch at the pharmacy. Often a more consistent intake routine resolves the problem — without a dose increase.
Levothyroxine hair loss — when does it stop? Hair loss is common in the adjustment phase and worries many patients. It can occur with both underdosage and overdosage — and also when the dose has just been optimised, because the hair follicle cycle responds with a delay. In most cases, hair loss normalises after 3–6 months of stable dosing. Persistent hair loss after more than 6 months with a stable TSH should be investigated for other causes (iron, zinc, vitamin D).
Levothyroxine morning or evening — which is better? Pharmacologically, the evening is at least equivalent, and tends to be slightly better — because the empty stomach at night provides ideal conditions. For many patients the evening schedule is easier to maintain, as no waiting time before breakfast is needed. The only condition: the last meal must have been at least 2–3 hours earlier. Anyone switching should have TSH checked after 6–8 weeks.